Viewing nowSelmetec Tablet 10 mg (Olmesartan Medoxomil)
Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

MFDS item code 201504106 · Approved 2015.06.23 · Insurance code 693901550
Treatment of essential hypertension
Essential hypertension is a condition where blood pressure is persistently high without a specific cause, and medications are used to treat it. The purpose of such treatment is to stabilize blood pressure and prevent damage to major organs such as the heart and kidneys. Patients are advised to consistently take the medication while also improving their lifestyle. With appropriate treatment, essential hypertension can be effectively managed.
1. Adults The recommended initial dose is 10 mg once daily, taken regardless of meals. If blood pressure is not adequately controlled at this dose, increase to 20 mg once daily. If additional blood pressure reduction is required, the dose may be increased to a maximum of 40 mg once daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered in combination with a thiazide diuretic, such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). For patients who may have reduced effective circulating blood volume (e.g., patients taking diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. 2. Older adults No dosage adjustment is required when this medicine is administered to older adults aged 65 years or older. Although no overall differences in efficacy or safety have been observed between older and younger patients, the possibility of a more sensitive response in some older adults cannot be excluded. 3. Patients with renal impairment The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. 4. Patients with hepatic impairment No dosage adjustment is required for patients with mild hepatic impairment. For patients with moderate hepatic impairment, the recommended initial dose is 10mg once daily, which may be increased to a maximum of 20mg per day. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.
The safety and efficacy in children have not been established.
This medication can cause severe harm or even death to the fetus and newborns when administered to pregnant women in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. This medication should not be used in patients with allergies to its components, pregnant or breastfeeding women, patients on renal dialysis, those with severe liver dysfunction, biliary obstruction, certain genetic lactose intolerance, and diabetic patients with moderate to severe renal impairment who are taking aliskiren. Patients with reduced blood volume or low sodium should be cautious as initial hypotension may occur when starting this medication, and patients dependent on renal function should be closely monitored for worsening kidney function. There is also a risk of hyperkalemia with this medication, so patients with heart failure or kidney dysfunction should have their serum potassium levels checked regularly. Dizziness may occur while taking this medication, so it is advisable to avoid driving or operating dangerous machinery. Various adverse reactions have been reported with this medication, which are generally mild and temporary, including dizziness, headache, back pain, gastrointestinal disturbances, etc. Serious side effects such as chronic diarrhea with weight loss, chronic malabsorption syndrome, and intestinal vascular edema have been reported infrequently, and immediate consultation with a healthcare professional is necessary if such symptoms appear. This medication may dangerously raise serum potassium levels when taken with potassium-sparing diuretics or potassium supplements, so caution is required if used together. Additionally, when used with other antihypertensives, the blood pressure-lowering effect may increase, so it should be taken according to a healthcare professional's instructions. The use of lithium with this medication may lead to elevated serum lithium levels and toxicity, so it is not recommended to be used together. Taking non-steroidal anti-inflammatory drugs with this medication may worsen kidney function, so caution is necessary. This medication can have serious effects on the fetus during pregnancy, so it is essential to consult a healthcare professional if pregnant or planning to become pregnant. If breastfeeding, this medication may pass into breast milk and cause adverse reactions in infants, so consideration should be given to stopping breastfeeding or the medication. Safety in children has not been established; therefore, it is advisable not to use this medication in children. In elderly patients, the concentration of the drug in the body may increase, so dose adjustment and monitoring are necessary. Overdose may result in symptoms such as hypotension and palpitations; severe symptoms should be reported to a healthcare professional immediately. This medication has been reported to have a low risk of carcinogenicity or genotoxicity even with long-term use, but patients should not arbitrarily stop or change their medication without following their healthcare professional's instructions.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is advisable to maintain the storage temperature between 1 to 25 degrees Celsius.
White round film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlmesartan Medoxomil 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
JW Pharmaceutical Corp.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
DongKook Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.